Angiogenesis inhibitor formulated through nanotechnology shows promising anticancer results
The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston.
Nano technology has tremendous potential in areas of medicine and material science, former President APJ Abdul Kalam has said.